PDF(Pubmed)
Abstract：
Ogilvie syndrome is a rare disorder characterized by dilatation of part or all of the colon and rectum without intrinsic or extrinsic mechanical obstruction. Its etiology is likely multifactorial with high mortality if left untreated. Here, we report for the first time a case of Ogilvie syndrome secondary to the AngioVac procedure. Because our patient had a high operative risk, we used the AngioVac system to debulk tricuspid valve vegetations to reduce bacterial load. Although AngioVac is considered safe overall, publications describing its side effects, safety, and efficacy are limited. Providers should be aware of this rare but potentially fatal complication and the importance of close clinical monitoring and serial abdominal examinations following AngioVac procedures.
摘要：
Ogilvie综合征是一种罕见的疾病，其特征是部分或全部结肠和直肠扩张，没有内在或外在的机械性梗阻。如果不治疗，其病因可能是多因素的，死亡率很高。这里,我们首次报道一例因AngioVac手术继发的Ogilvie综合征.因为我们的病人手术风险很高，我们使用AngioVac系统清除三尖瓣植被以减少细菌负荷。虽然AngioVac总体上被认为是安全的，描述其副作用的出版物，安全,功效有限。提供者应意识到这种罕见但可能致命的并发症，以及在AngioVac程序后进行密切临床监测和连续腹部检查的重要性。
